Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autoimmune Diseases
Biotech
Kyorin pens $105M pact for Japan rights to Hinge's lupus drug
Kyorin has strengthened its autoimmune portfolio by paying $10 million upfront for the Japan rights to Hinge Bio’s preclinical lupus drug.
James Waldron
Oct 1, 2025 6:40am
Sitala seals $670M deal for Fosun immune disease drug
Aug 26, 2025 2:44pm
Generation Bio jettisons 90% of employees, including R&D org
Aug 13, 2025 5:00am
Novartis scores 3rd phase 3 win for ianalumab this week
Aug 12, 2025 5:09am
Novartis scores double phase 3 win in Sjögren's syndrome
Aug 11, 2025 4:33am
BMS hands 5 autoimmune drugs to Bain-backed spinout
Jul 29, 2025 5:08am
